Press Release

Back to Press Release List

SITC Poster Presentation: “KSQ-004: Unbiased Pair-wise Discovery of SOCS1 and Regnase-1 as the Top CRISPR/Cas9 Dual-edit Combination Enhancing In vivo TIL Potency Against Solid Tumors”

Click image to enlarge.

Click to download PDF file.

© 2022 KSQ Therapeutics, Inc. All rights reserved.